BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/21/2025 5:29:15 AM | Browse: 33 | Download: 17
 |
Received |
|
2025-04-28 11:36 |
 |
Peer-Review Started |
|
2025-04-28 11:37 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-05-24 02:42 |
 |
Revised |
|
2025-06-06 18:42 |
 |
Second Decision |
|
2025-07-14 02:43 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-07-28 08:29 |
 |
Articles in Press |
|
2025-07-28 08:29 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2025-08-11 07:11 |
 |
Publish the Manuscript Online |
|
2025-08-21 05:29 |
ISSN |
1948-0210 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Geriatrics & Gerontology |
Manuscript Type |
Review |
Article Title |
Mesenchymal stem cell-derived exosomes: Shaping the next era of Alzheimer’s disease treatment
|
Manuscript Source |
Invited Manuscript |
All Author List |
Xiao-Qian Shan, Mei-Heng He, Wei-Li Gao, Yu-Jiao Li, Shu-Zhen Liu, Yan Liu, Chao-Li Wang, Lan Zhao and Shi-Xin Xu |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Natural Science Foundation of China |
82074533 |
|
Corresponding Author |
Lan Zhao, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, No. 88 Changling Road, Xiqing District, Tianjin 300381, China. lanzhao69@163.com |
Key Words |
Alzheimer’s disease; Mesenchymal stem cells; Exosomes; Precision medicine; Cell-free therapy |
Core Tip |
Mesenchymal stem cell-derived exosomes represent a promising therapeutic modality for Alzheimer’s disease, owing to their biological functions and biocompatibility. Mesenchymal stem cell-derived exosomes facilitate the clearance of β-amyloid by carrying degradative enzymes, modulate neuroinflammation, and promote neurorestoration. While preclinical and clinical data are encouraging, challenges such as production standardization, safety, and long-term efficacy remain. Strategies like exosome functionalization, targeting optimization, gene editing, and synthetic exosomes may enhance therapeutic potential and accelerate clinical translation. |
Publish Date |
2025-08-21 05:29 |
Citation |
<p>Shan XQ, He MH, Gao WL, Li YJ, Liu SZ, Liu Y, Wang CL, Zhao L, Xu SX. Mesenchymal stem cell-derived exosomes: Shaping the next era of Alzheimer’s disease treatment. <i>World J Stem Cells</i> 2025; 17(8): 109006</p> |
URL |
https://www.wjgnet.com/1948-0210/full/v17/i8/109006.htm |
DOI |
https://dx.doi.org/10.4252/wjsc.v17.i8.109006 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345